Skip to main content
Top
Published in: Ophthalmology and Therapy 2/2019

Open Access 01-06-2019 | Glaucoma | Case Series

Trabeculectomy with Suprachoroidal Derivation in Eyes with Uncontrolled Glaucoma: A Case Series with a 24-Month Follow-up

Authors: Rodolfo A. Perez-Grossmann, Daniel E. Grigera, Alan Wenger

Published in: Ophthalmology and Therapy | Issue 2/2019

Login to get access

Abstract

Introduction

The aim of this study was to evaluate the efficacy of trabeculectomy with suprachoroidal derivation in eyes with uncontrolled glaucoma after a 24-month follow-up period.

Methods

This was a prospective uncontrolled non-randomized case series. All patients scheduled for a trabeculectomy due to uncontrolled glaucoma at the “Instituto de Glaucoma y Catarata” (Lima, Peru) between 2011 and 2014 were included. Thee patients underwent trabeculectomy with mitomycin C and suprachoroidal derivation with two autologous scleral flaps. Postsurgical follow-up visits took place on day 1, and at 1, 6, 12, 18 and 24 months. Best corrected visual acuity (BCVA), intraocular pressure (IOP) and complications at each control were registered. Main outcome measures were IOP reduction, number of glaucoma medications and complication rate. Postoperative IOP of > 21 mmHg, < 5 mmHg, additional glaucoma surgery or severe complications were considered as indications of failure.

Results

Thirty-three participants (41 eyes) were included in the study, of whom 27 (81.82%) (31 eyes [75.61%]) finished the 24 months of follow-up. At the end of the follow-up, mean IOP had decreased by 11.29 ± 9.32 mmHg (p < 0.001), and glaucoma medication usage in 25 (25/31; 80.65%) eyes had stopped. Ten (10/41; 24.39%) patients complained of blurred vision, and 15 (15/41; 36.59%) patients referred to foreign body sensation the first day after surgery; both sensations resolved spontaneously after 1 week in all cases. No failures, significant changes in BCVA (p = 0.387) or severe complications were found.

Conclusions

In this case series, trabeculectomy with suprachoroidal derivation exhibited high efficacy and safety after a 24-month follow-up. A larger sample with a control group is needed to confirm our initial findings.
Literature
1.
go back to reference World Health Organization. The world health report 2003: shaping the future. Geneva: World Health Organization; 2003.CrossRef World Health Organization. The world health report 2003: shaping the future. Geneva: World Health Organization; 2003.CrossRef
2.
go back to reference Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–7.CrossRef Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–7.CrossRef
4.
go back to reference Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108(11):1943–53.CrossRef Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108(11):1943–53.CrossRef
5.
go back to reference Janz NK, Wren PA, Lichter PR, et al. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology. 2001;108(11):1954–65.CrossRef Janz NK, Wren PA, Lichter PR, et al. The Collaborative Initial Glaucoma Treatment Study: interim quality of life findings after initial medical or surgical treatment of glaucoma. Ophthalmology. 2001;108(11):1954–65.CrossRef
6.
go back to reference Burr J, Azuara-Blanco A, Avenell A, Tuulonen A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev. 2012;9:CD004399. Burr J, Azuara-Blanco A, Avenell A, Tuulonen A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev. 2012;9:CD004399.
7.
go back to reference Boland MV, Ervin A-M, Friedman DS, et al. Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2013;158(4):271–9.CrossRef Boland MV, Ervin A-M, Friedman DS, et al. Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2013;158(4):271–9.CrossRef
8.
go back to reference Olayanju JA, Hassan MB, Hodge DO, Khanna CL. Trabeculectomy-related complications in Olmsted County, Minnesota, 1985 through 2010. JAMA Ophthalmol. 2015;133(5):574–80.CrossRef Olayanju JA, Hassan MB, Hodge DO, Khanna CL. Trabeculectomy-related complications in Olmsted County, Minnesota, 1985 through 2010. JAMA Ophthalmol. 2015;133(5):574–80.CrossRef
9.
go back to reference Jampel HD, Musch DC, Gillespie BW, Lichter PR, Wright MM, Guire KE. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol. 2005;140(1):16–22.CrossRef Jampel HD, Musch DC, Gillespie BW, Lichter PR, Wright MM, Guire KE. Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol. 2005;140(1):16–22.CrossRef
10.
go back to reference DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002;120(3):297–300.CrossRef DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol. 2002;120(3):297–300.CrossRef
11.
go back to reference Picht G, Mutsch Y, Grehn F. Follow-up of trabeculectomy. Complications and therapeutic consequences. Ophthalmol Z Dtsch Ophthalmol Ges. 2001;98(7):629–34. Picht G, Mutsch Y, Grehn F. Follow-up of trabeculectomy. Complications and therapeutic consequences. Ophthalmol Z Dtsch Ophthalmol Ges. 2001;98(7):629–34.
12.
go back to reference Gedde SJ, Schiffman JC, Feuer WJ, et al. Three-year follow-up of the tube versus trabeculectomy study. Am J Ophthalmol. 2009;148(5):670–84.CrossRef Gedde SJ, Schiffman JC, Feuer WJ, et al. Three-year follow-up of the tube versus trabeculectomy study. Am J Ophthalmol. 2009;148(5):670–84.CrossRef
13.
go back to reference Brusini P, Filacorda S. Enhanced Glaucoma Staging System (GSS 2) for classifying functional damage in glaucoma. J Glaucoma. 2006;15(1):40–6.CrossRef Brusini P, Filacorda S. Enhanced Glaucoma Staging System (GSS 2) for classifying functional damage in glaucoma. J Glaucoma. 2006;15(1):40–6.CrossRef
14.
go back to reference Jordan JF, Engels BF, Dinslage S, et al. A novel approach to suprachoroidal drainage for the surgical treatment of intractable glaucoma. J Glaucoma. 2006;15(3):200–5.CrossRef Jordan JF, Engels BF, Dinslage S, et al. A novel approach to suprachoroidal drainage for the surgical treatment of intractable glaucoma. J Glaucoma. 2006;15(3):200–5.CrossRef
15.
go back to reference Unal M, Kocak Altintas AG, Koklu G, Tuna T. Early results of suprachoroidal drainage tube implantation for the surgical treatment of glaucoma. J Glaucoma. 2011;20(5):307–14.CrossRef Unal M, Kocak Altintas AG, Koklu G, Tuna T. Early results of suprachoroidal drainage tube implantation for the surgical treatment of glaucoma. J Glaucoma. 2011;20(5):307–14.CrossRef
16.
go back to reference Bindlish R, Condon GP, Schlosser JD, D’Antonio J, Lauer KB, Lehrer R. Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up. Ophthalmology. 2002;109(7):1336–41.CrossRef Bindlish R, Condon GP, Schlosser JD, D’Antonio J, Lauer KB, Lehrer R. Efficacy and safety of mitomycin-C in primary trabeculectomy: five-year follow-up. Ophthalmology. 2002;109(7):1336–41.CrossRef
17.
go back to reference Fontana H, Nouri-Mahdavi K, Caprioli J. Trabeculectomy with mitomycin C in pseudophakic patients with open-angle glaucoma: outcomes and risk factors for failure. Am J Ophthalmol. 2006;141(4):652–9.CrossRef Fontana H, Nouri-Mahdavi K, Caprioli J. Trabeculectomy with mitomycin C in pseudophakic patients with open-angle glaucoma: outcomes and risk factors for failure. Am J Ophthalmol. 2006;141(4):652–9.CrossRef
18.
go back to reference Gedde SJ, Lee RK. Comparing glaucoma drainage implants. Am J Ophthalmol. 2010;149(6):875–7.CrossRef Gedde SJ, Lee RK. Comparing glaucoma drainage implants. Am J Ophthalmol. 2010;149(6):875–7.CrossRef
19.
go back to reference Epstein E. Fibrosing response to aqueous. Its relation to glaucoma. Br J Ophthalmol. 1959;43:641–7.CrossRef Epstein E. Fibrosing response to aqueous. Its relation to glaucoma. Br J Ophthalmol. 1959;43:641–7.CrossRef
20.
go back to reference Hovakimyan M, Siewert S, Schmidt W, et al. Development of an experimental drug eluting suprachoroidal microstent as glaucoma drainage device. Transl Vis Sci Technol. 2015;4(3):14.CrossRef Hovakimyan M, Siewert S, Schmidt W, et al. Development of an experimental drug eluting suprachoroidal microstent as glaucoma drainage device. Transl Vis Sci Technol. 2015;4(3):14.CrossRef
21.
go back to reference Francis BA, Singh K, Lin SC, et al. Novel glaucoma procedures: a report by the American Academy of Ophthalmology. Ophthalmology. 2011;118(7):1466–80.CrossRef Francis BA, Singh K, Lin SC, et al. Novel glaucoma procedures: a report by the American Academy of Ophthalmology. Ophthalmology. 2011;118(7):1466–80.CrossRef
22.
go back to reference Emi K, Pederson JE, Toris CB. Hydrostatic pressure of the suprachoroidal space. Invest Ophthalmol Vis Sci. 1989;30(2):233–8.PubMed Emi K, Pederson JE, Toris CB. Hydrostatic pressure of the suprachoroidal space. Invest Ophthalmol Vis Sci. 1989;30(2):233–8.PubMed
23.
go back to reference Moisseiev E, Loewenstein A, Yiu G. The suprachoroidal space: from potential space to a space with potential. Clin Ophthalmol Auckl NZ. 2016;10:173–8.CrossRef Moisseiev E, Loewenstein A, Yiu G. The suprachoroidal space: from potential space to a space with potential. Clin Ophthalmol Auckl NZ. 2016;10:173–8.CrossRef
24.
go back to reference Saliba JB, Vieira L, Fernandes-Cunha GM, et al. Anti-Inflammatory effect of dexamethasone controlled released from anterior suprachoroidal polyurethane implants on endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci. 2016;57(4):1671–9.CrossRef Saliba JB, Vieira L, Fernandes-Cunha GM, et al. Anti-Inflammatory effect of dexamethasone controlled released from anterior suprachoroidal polyurethane implants on endotoxin-induced uveitis in rats. Invest Ophthalmol Vis Sci. 2016;57(4):1671–9.CrossRef
25.
go back to reference Skaat A, Sagiv O, Kinori M, Ben Simon GJ, Goldenfeld M, Melamed S. Gold micro- shunt implants versus ahmed glaucoma valve: long-term outcomes of a prospective randomized clinical trial. J Glaucoma. 2016;25(2):155–61.CrossRef Skaat A, Sagiv O, Kinori M, Ben Simon GJ, Goldenfeld M, Melamed S. Gold micro- shunt implants versus ahmed glaucoma valve: long-term outcomes of a prospective randomized clinical trial. J Glaucoma. 2016;25(2):155–61.CrossRef
26.
go back to reference Melamed S, Ben Simon GJ, Goldenfeld M, Simon G. Efficacy and safety of gold micro shunt implantation to the supraciliary space in patients with glaucoma: a pilot study. Arch Ophthalmol Chic Ill 1960. 2009;127(3):264–9.CrossRef Melamed S, Ben Simon GJ, Goldenfeld M, Simon G. Efficacy and safety of gold micro shunt implantation to the supraciliary space in patients with glaucoma: a pilot study. Arch Ophthalmol Chic Ill 1960. 2009;127(3):264–9.CrossRef
27.
go back to reference Höh H, Grisanti S, Grisanti S, Rau M, Ianchulev S. Two-year clinical experience with the CyPass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent. Klin Monatsbl Augenheilkd. 2014;231(4):377–81.CrossRef Höh H, Grisanti S, Grisanti S, Rau M, Ianchulev S. Two-year clinical experience with the CyPass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent. Klin Monatsbl Augenheilkd. 2014;231(4):377–81.CrossRef
28.
go back to reference Hoeh H, Vold SD, Ahmed IK, et al. Initial clinical experience with the cypass micro-stent: safety and surgical outcomes of a novel supraciliary microstent. J Glaucoma. 2016;25(1):106–12.CrossRef Hoeh H, Vold SD, Ahmed IK, et al. Initial clinical experience with the cypass micro-stent: safety and surgical outcomes of a novel supraciliary microstent. J Glaucoma. 2016;25(1):106–12.CrossRef
29.
go back to reference Figus M, Lazzeri S, Fogagnolo P, Iester M, Martinelli P, Nardi M. Supraciliary shunt in refractory glaucoma. Br J Ophthalmol. 2011;95(11):1537–41.CrossRef Figus M, Lazzeri S, Fogagnolo P, Iester M, Martinelli P, Nardi M. Supraciliary shunt in refractory glaucoma. Br J Ophthalmol. 2011;95(11):1537–41.CrossRef
30.
go back to reference Minckler DS, Francis BA, Hodapp EA, et al. Aqueous shunts in glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology. 2008;115(6):1089–98.CrossRef Minckler DS, Francis BA, Hodapp EA, et al. Aqueous shunts in glaucoma: a report by the American Academy of Ophthalmology. Ophthalmology. 2008;115(6):1089–98.CrossRef
31.
go back to reference Yablonski ME. Trabeculectomy with internal tube shunt: a novel glaucoma surgery. J Glaucoma. 2005;14(2):91–7.CrossRef Yablonski ME. Trabeculectomy with internal tube shunt: a novel glaucoma surgery. J Glaucoma. 2005;14(2):91–7.CrossRef
Metadata
Title
Trabeculectomy with Suprachoroidal Derivation in Eyes with Uncontrolled Glaucoma: A Case Series with a 24-Month Follow-up
Authors
Rodolfo A. Perez-Grossmann
Daniel E. Grigera
Alan Wenger
Publication date
01-06-2019
Publisher
Springer Healthcare
Published in
Ophthalmology and Therapy / Issue 2/2019
Print ISSN: 2193-8245
Electronic ISSN: 2193-6528
DOI
https://doi.org/10.1007/s40123-019-0179-5

Other articles of this Issue 2/2019

Ophthalmology and Therapy 2/2019 Go to the issue